It is well established that during the development and maintenance of the MDR phenotype, one of the key MDR-associated targets of miR-17 is the Akt signaling regulator phosphatase and tensin homolog (PTEN), as demonstrated in resistant colorectal cancer (CRC) cells [6]. Here, PTEN is linked to colorectal carcinoma.